TNF and rheumatoid arthritis: Decreased influx of neutrophils in inflamed joints was reported by Taylor and coworkers [14] in RA patients treated with infliximab (a chimeric anti-TNF-α mAb) and by Den Broeder and coworkers [15] in patients treated with adalimumab (a fully human anti-TNF-α mAb).